GNLAF yields 6.03% · MRK yields 2.76%● Live data
📍 GNLAF pulled ahead of the other in Year 1
Combined, GNLAF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GNLAF + MRK for your $10,000?
Genesis Land Development Corp., an integrated land developer and residential home builder, owns and develops a portfolio of residential lands and serviced lots in the Calgary Metropolitan Area, Canada. It operates through two segments, Land Development and Home Building. The Land Development segment acquires, plans, rezones, subdivides, services, and sells residential lots, and commercial and industrial lands to third-party developers and builders. The Home Building segment designs, constructs, and sells single-family and semi-detached homes and townhomes. The company was formerly known as Genesis Capital Corp. and changed its name to Genesis Land Development Corp. in October 1998. Genesis Land Development Corp. was founded in 1991 and is headquartered in Calgary, Canada.
Full GNLAF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.